advertisement
Bron A 53
Showing records 1 to 25 | Display only abstracts from Bron A in IGR 15-294743 National Health Care data system analysis of glaucoma surgery activity in France in 2016
Dufournet J; Chiquet C; Bouisse M; Francois P; Bron A; Boussat B; Daien V; Bourcier T; Robert PY; Aptel F
Acta Ophthalmologica 2022; 100: e478-e490 (IGR: 22-2)
86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Chamard C
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)
86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Chamard C
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)
86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Larrieu S
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)
86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Villain M; Bron A
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)
86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Baudouin C
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)
86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Causse A
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)
86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Bron A; Villain M
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)
86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Bentaleb Y
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)
86597 Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Daien V
Acta Ophthalmologica 2020; 98: e876-e881 (IGR: 21-2)
86282 Prevalence of Unknown Ocular Hypertension, Glaucoma Suspects, and Glaucoma in Patients Seen in an Ophthalmology Center in France
Pelen F; Baudouin C; Daien V
Ophthalmic Research 2020; 63: 295-301 (IGR: 21-2)
65975 Multicenter clinical trial of high-intensity focused ultrasound treatment in glaucoma patients without previous filtering surgery
Aptel F; Denis P; Rouland JF; Renard JP; Bron A
Acta Ophthalmologica 2016; 94: e268-e277 (IGR: 17-3)
60303 Cyclocoagulation of the ciliary bodies by high-intensity focused ultrasound: a 12-month multicenter study
Denis P; Aptel F; Rouland JF; Nordmann JP; Lachkar Y; Renard JP; Sellem E; Baudouin C; Bron A
Investigative Ophthalmology and Visual Science 2015; 56: 1089-1096 (IGR: 16-4)
59588 Glaucoma medications, preservatives and the ocular surface
Aptel F; Labbé A; Baudouin C; Bron A; Lachkar Y; Sellem E; Renard JP; Nordmann JP; Rouland JF; Denis P
Journal Français d'Ophtalmologie 2014; 37: 728-736 (IGR: 16-3)
55978 FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis
Brillat-Zaratzian E; Bron A; Aptel F; Romanet JP; Cornut PL; Vandenesch F; Boisset S; Maurin M; Chiquet C
Graefe's Archive for Clinical and Experimental Ophthalmology 2014; 252: 101-107 (IGR: 16-1)
54015 A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
Pfennigsdorf S; de Jong L; Makk S; Fournichot Y; Bron A; Morgan-Warren RJ; Maltman J
Clinical Ophthalmology 2013; 7: 1219-1225 (IGR: 15-2)
52484 Preservative-free treatment in glaucoma: who, when, and why
Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
European Journal of Ophthalmology 2013; 23: 0 (IGR: 15-1)
51304 Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat
Fourgeux C; Martine L; Pasquis B; Maire MA; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
Acta Ophthalmologica 2012; 90: e560-e567 (IGR: 14-3)
49156 Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study
Renard JP; Rouland JF; Bron A; Sellem E; Nordmann JP; Baudouin C; Denis P; Villain M; Chaine G; Colin J; de Pouvourville G; Pinchinat S; Moore N; Estephan M; Delcourt C
Acta Ophthalmologica 2013; 91: 505-513 (IGR: 14-1)
46673 Role of community pharmacist in the management of patients in ophthalmology
Delolme M-P; Law-Ki A; Belon J-P; Creuzot-Garcher C; Bron A
Journal Français d'Ophtalmologie 2011; 34: 168-174 (IGR: 13-3)
45617 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma
Fourgeux C; Bron A; Acar N; Creuzot-Garcher C; Bretillon L
Chemistry and Physics of Lipids 2011; 164: 496-499 (IGR: 13-2)
26119 Treatment of Glaucoma in Clinical Practice: Four-year Results From a Patient Registry in France
Kobelt G; Texier-Richard B; Buchholz P; Bron A; Renard JP; Rouland JF; Nordmann JP
Journal of Glaucoma 2010; 19: 199-206 (IGR: 12-2)
24920 Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels
Fourgeux C; Martine L; Björkhem I; Diczfalusy U; Joffre C; Acar N; Creuzot-Garcher C; Bron A; Bretillon L
Investigative Ophthalmology and Visual Science 2009; 50: 5712-5717 (IGR: 11-4)
24648 One-day cross sectional study in Glaucoma
Nordmann JP; Baudouin C; Bron A; Denis P; Renard JP; Rouland JF; Sellem E; Estphan M; Kosa M
Value in Health 2009; 12: A458 (IGR: 11-4)
24861 Xal-Ease(R): impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction
Nordmann JP; Baudouin C; Bron A; Denis P; Rouland JF; Sellem E; Renard JP
European Journal of Ophthalmology 2009; 19: 949-956 (IGR: 11-4)
